Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Boca Pharmacal Receives FDA Approval for Generic Version of Panlor(R)SS.


Signs Exclusive Marketing and Distribution Agreement with Tedor Pharma for Generic Version of Didrex[R]

CORAL SPRINGS Coral Springs, city (1990 pop. 79,443), Broward co., SE Fla.; inc. 1963. Largely residential, it is a city that has grown rapidly along with the southern Florida and Fort Lauderdale area. The population of Coral Springs nearly doubled between 1980 and 1990. , Fla. -- Boca Pharmacal, Inc. made two major announcements today with the U.S. Food and Drug Administration granting its final approval for the Company's Abbreviated New Drug Application abbreviated new drug application Pharmacology An application made in the US by a pharmaceutical company requesting authority to market a 'new' drug for which both its therapeutic indications and formulation were previously approved by the FDA in another similar  (ANDA ANDA
abbr.
abbreviated new drug application
) to market its generic version of and Panlor[R]SS (Acetaminophen acetaminophen (əsēt'əmĭn`əfĭn), an analgesic and fever-reducing medicine similar in effect to aspirin. It is an active ingredient in many over-the-counter medicines, including Tylenol and Midol. , Caffeine and Dihydrocodeine) and the signing of an exclusive marketing and distribution agreement with Tedor Pharma Inc. for Didrex[R] (Benzphetamine Hydrochloride hydrochloride /hy·dro·chlo·ride/ (-klor´id) a salt of hydrochloric acid.

hy·dro·chlo·ride
n.
A compound resulting from the reaction of hydrochloric acid with an organic base.
). Boca Pharmacal also announced that the company plans to launch both products immediately.

Exclusive Marketing Agreement with Tedor to Market Generic Version of Didrex[R]

The agreement with Tedor Pharma provides Boca Pharmacal with exclusive marketing and distribution rights for the generic version of Didrex[R] (Benzphetamine Hydrochloride) in 50mg tablet formats for oral administration. Benzphetamine Hydrochloride is used to decrease appetite in overweight and obese patients. "Boca Pharmacal and Tedor Pharma share the same corporate vision of offering top quality products manufactured and marketed in accordance with FDA FDA
abbr.
Food and Drug Administration


FDA,
n.pr See Food and Drug Administration.

FDA,
n.pr the abbreviation for the Food and Drug Administration.
 regulations in a professional manner," said Theodore Iorio, President of Tedor Pharma.

FDA Approval for Generic Version of Panlor[R]SS

Boca Pharmacal also received final ANDA approval to market the generic version of Panlor[R]SS, Acetaminophen, Caffeine, and Dihydrocodeine Bitartrate di·hy·dro·co·deine bitartrate
n.
A narcotic analgesic derived from codeine, about one-sixth as potent as morphine.
 in tablet form for oral administration to treat moderate to severe pain. Each tablet contains the following: Acetaminophen 712.8 mg, Caffeine 60 mg and Dihydrocodeine, 32 mg.

"We are very pleased to extend our longstanding relationship with Tedor Pharma with this exclusive marketing and distribution agreement," said Robert J Edwards Jr., Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Boca Pharmacal. "Our latest approval represents another significant advancement for our company by increasing our generic product offerings and value priced alternatives for consumers. In addition to the approval of generic Panlor[R]SS, we expect five more approvals as well as filing 14 ANDA submissions during 2007."

Boca Pharmacal's mission is to focus on delivering specialty type products that may have been overlooked by some of the larger generic companies. Both Acetaminophen, Caffeine and Dihydrocodeine (generic version of Panlor[R]SS) and Benzphetamine Hydrochloride (generic version of Didrex[R]) meet our criteria of offering lower volume but important drugs to patients in need.

Founded in 1998 Coral Springs, FL-based Boca Pharmacal manufactures, develops and distributes a wide variety of generic drugs. For more information please visit http://www.bocapharmacal.com.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 10, 2007
Words:396
Previous Article:nextSource Updates The People Ticker (TM), the Industry's Only Real-time Rate and Salary Benchmarking Tool.
Next Article:Sector and Individual Company Analysis of the Hosiery, Lingerie & Underwear Industry.
Topics:



Related Articles
Hi-Tech Pharmacal reports FDA and ANDA approval for generic drug used in treatment of seizures; FDA approval is company's third in 90-day period.
Hi-Tech Pharmacal Receives FDA Approval to Market Generic Form of Phenergan with Codeine Phosphate Syrup.
FAULDING TO MARKET ENALAPRILAT INJECTION/ENALAPRIL TABLETS.
FDA APPROVES BIOVAIL'S GENERIC PROCARDIA XL 30MG DOSAGE.
Consumer class actions follow suits by generic drug makers against brand-name companies.
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R).
FDA APPROVES TEVA'S ANDA TO MARKET GENERIC VERSION OF ZOCOR.
IMPAX Receives Final FDA Approval and First-to-File Status for Generic Version of Ditropan(R) XL 15 mg.
IMPAX Receives Final FDA Approval for Generic Ditropan(R) XL 5 mg and 10 mg.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles